Smartwatches may transform blood sugar tracking, but today’s advances depend on CGMs, AI, and regulated health tech ...
DexCom (DXCM) faces GLP-1 disruption as it targets non-insulin Type 2 CGM growth. Read here for a detailed invesment analysis ...
Morning Overview on MSN
The FDA cleared the first over-the-counter glucose monitor made for children
Parents of young children with elevated blood sugar now have a new option that does not require a doctor’s prescription. The Food and Drug Administration cleared Dexcom’s Stelo Glucose Biosensor ...
AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...
A new initiative integrated personal continuous glucose monitor reports into routine primary care visits for diabetes.
Compare the Apple Watch, Samsung Galaxy Watch, and Pixel Watch for blood sugar tracking, CGM alerts, health trends, battery ...
The FDA gave the green light to Dexcom’s popular over-the-counter glucose monitor Stelo for children 2 years or older who don’t use insulin. (Dexcom) The FDA has given the green light to Dexcom’s ...
The CONNECT trial, presented at the American Diabetes Association’s 2026 Scientific Sessions in New Orleans, found that 82% of adults with type 2 diabetes who used a Dexcom G7 improved their blood ...
NEW ORLEANS — Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to improved blood sugar control in patients with type 2 diabetes not using insulin, compared with ...
June 6 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab said the use of its continuous glucose monitor, G7, led to improved blood sugar control in patients with type 2 diabetes not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results